goBalto

San Francisco, United States Founded: 2008 • Age: 18 yrs Acquired By Oracle
Cloud-based SaaS solutions for clinical trial startup are offered.
Annual revenue - Latest available
Total funding $38.2M 7 rounds
Employees 66 Tracked headcount
Investors 8 Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About goBalto

goBalto is a company based in San Francisco (United States) founded in 2008 was acquired by Oracle in October 2018. goBalto has raised $38.25 million across 7 funding rounds from investors including Qualcomm, Oracle and Mitsui Global Investment. The company has 66 employees as of December 31, 2017. goBalto operates in a competitive market with competitors including Inato, NoviSci, Acme Clinical Trials, AltaVoice and Dementias Platform, among others.

  • Headquarter San Francisco, United States
  • Employees 66 as on 31 Dec, 2017
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $38.25 M (USD)

    in 7 rounds

  • Latest Funding Round
    $12.11 M (USD), Series C

    Jan 06, 2015

  • Investors
    Qualcomm

    & 7 more

  • Employee Count
    66

    as on Dec 31, 2017

  • Acquired by
    Oracle

    (Oct 17, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of goBalto

goBalto has successfully raised a total of $38.25M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $12.11 million completed in January 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in goBalto

goBalto has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Qualcomm, Oracle and Mitsui Global Investment.

All
Venture Fund
Institutional
Angel
Investor Description Founded Year Domain Location
Corporate-backed venture capital firm focused on healthcare, IT, and multiple sectors
Locked Locked Locked
Venture capital fund focused on early-stage biotech, life sciences, IT, and multiple sectors
Locked Locked Locked
Government-backed investments are directed toward healthcare, fintech, and various sectors.
Locked Locked Locked
Premium access

Investor details for goBalto

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by goBalto

Investments
Premium access

Investment portfolio details for goBalto

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - goBalto

Premium access

Detailed financials for goBalto

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Gobalto Comparisons

goBalto Primary company
Description
Cloud-based SaaS solutions for clinical trial startup are of...
Location
San Francisco, United States
Founded Year
2008
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
66
As of 2017
Premium access

Peer comparison for goBalto

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of goBalto

goBalto operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inato, NoviSci, Acme Clinical Trials, AltaVoice and Dementias Platform, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
AI-based patient recruitment platform
Locked Locked Locked
Provider of an online scientific sourcing tool for researchers and professionals
Locked Locked Locked
Provides an online database of clinical trial studies for researchers.
Locked Locked Locked
Patient Insight Network (PIN) helping drug developers find better treatments for diseases
Locked Locked Locked
Platform for dementia research, data access, and clinical trials collaboration.
Premium access

Detailed competitors of goBalto

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Gobalto

Oracle Buys goBalto
Prnewswire7 years ago
goBalto Releases Latest Version of goBalto Analyze
Pharmoutsourcing8 years ago
Premium access

Complete news archive for goBalto

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about goBalto

goBalto was founded in 2008 and raised its 1st funding round 1 year after it was founded.

goBalto is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.

goBalto is a funded company, having raised a total of $38.25M across 7 funding rounds to date.

As of Dec 31, 2017, the latest employee count at goBalto is 66.

goBalto provides cloud-based electronic solutions for clinical trial design, data capture analysis. It has three products: SELECT for optimising site selection, ACTIVATE for starting and designing clinical trials and ANALYZE for analysing the electronic data captured through Activate. All its products and solutions are in compliance with 21 CFR Part 11. The company claims that it can help in reducing cycle times by over 30, to have activated 38000 sites in 70 countries and over 75 adoption by global pharma companies and CROs. The companys platform can be used for site identification, feasibility assessment and selection, site activation and also to track adherence to timelines and budget.The companys clientele includes Covance, CMIC HOLDINGS, Genentech Roche, ICON, INC Research and Novartis.

goBalto's top competitors include Inato, NoviSci and AltaVoice.

goBalto has 8 investors. Key investors include Qualcomm, Oracle, Mitsui Global Investment, Dolby Family Ventures, and EDBI.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available